TXMD Stock Analysis: Buy, Sell, or Hold?
TXMD - TherapeuticsMD, Inc.
$2.04
0.04 (2.00%)
▲
5d:
+4.08%
30d:
-1.45%
90d:
-11.3%
BUY
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Get Alerted When TXMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TXMD shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: TXMD shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TXMD is currently trading at $2.04, which is considered fair relative to its 30-day fair value range of $2.00 to $2.13.
Technical Outlook: Technically, TXMD is showing sideways momentum. The price is approaching resistance at $2.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+150.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TXMD is showing sideways momentum. The price is approaching resistance at $2.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+150.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.00 -
$2.13
Company Quality Score
65/100
(BUY)
Options IV Signal
38th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 38th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 150.0% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$2.00 -
$2.13
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.40
(19.5%)
Support & Resistance Levels
Support Level
$1.92
Resistance Level
$2.10
Current Trend
Sideways
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.33
Wall Street Target
$5.00
(+150.0%)
Revenue Growth (YoY)
84.2%
Profit Margin
5.3%
Share & Embed Analysis
Last updated: May 18, 2026 2:48 PM ET
Data refreshes hourly during market hours. Next update: 3:48 PM
Data refreshes hourly during market hours. Next update: 3:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXMD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tommy G Thompson
BUY
8400 shares
2025-12-23
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 55 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$131 | 54 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$40 | 58 HOLD |
